McKesson
MCK
#189
Rank
NZ$193.01 B
Marketcap
NZ$1,564
Share price
-1.43%
Change (1 day)
35.47%
Change (1 year)
McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools.

EPS for McKesson (MCK)

EPS in 2025 (TTM): NZ$60.12

According to McKesson's latest financial reports the company's current EPS (TTM) is NZ$58.80. an increase over its 2024 EPS that were of NZ$36.98.

EPS history for McKesson from 2014 to 2025

Annual EPS

Year EPS Change
2025NZ$58.5558.33%
2024NZ$36.98-1.17%
2023NZ$37.421%
2022NZ$37.05144.72%
2021NZ$15.14-133.49%
2020NZ-$45.20451.13%
2019NZ-$8.20266.17%
2018NZ-$2.24-105.85%
2017NZ$38.29166.28%
2016NZ$14.380.71%
2015NZ$14.2814.44%
2014NZ$12.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Cerner
CERN
NZ$3.37-94.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Henry Schein
HSIC
NZ$5.37-90.86%๐Ÿ‡บ๐Ÿ‡ธ USA
AmerisourceBergen
ABC
NZ$13.96-76.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
NZ$11.21-80.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Premier
PINC
NZ-$0.45-100.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Patterson Companies
PDCO
NZ$2.63-95.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Computer Programs and Systems
CPSI
NZ-$5.30-109.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Veradigm
MDRX
NZ$0.84-98.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Owens & Minor
OMI
NZ-$29.31-149.84%๐Ÿ‡บ๐Ÿ‡ธ USA